Media RecognitionWall Street Journal

Mark Warner Quoted in the Wall Street Journal on the Halt on Administering the AstraZeneca COVID19 Vaccines to People Under the Age of 55 in Canada

Mark Warner was featured in the Wall Street Journal talking about the National Advisory Committee on Immunization recommendation that Canadian governments halt on administering the AstraZeneca COVID19 vaccines to people under the age of 55 . (March 29, 2021) Mr. Warner is a Canadian and U.S. lawyer who has practiced in Toronto, Washington, D.C., New York and Brussels and has advised governments on trade policy and trade negotiations and previously worked on trade and competition issues as counsel in the OECD Trade Directorate.

Mr. Warner has assisted pharmaceutical clients in the global distribution of HIV / AIDS anti-retroviral drugs and the development of innovative patient access programs in the developing world, advised a U.S.-based pharmaceutical company and its French and South African subsidiaries in a cartel investigation involving 11 leading global Pharmaceutical companies in South Africa and advised a U.S.-based pharmaceutical company on competition law issues relating to the distribution of various nuclear medicine imaging agents in Canada. Mr. Warner was Legal Director of the Ontario Ministry of Economic Development & Trade and advised Ontario on the negotiations of the Canada-EU Trade Agreement (CETA) including on IP, patent litigation and drug reimbursement issues and on economic development, research and innovation grants and loans to corporations, including leading global pharmaceutical companies for research, manufacture and clinical trial projects. As Legal Director of the Ontario Ministry of Research and Innovation, Mr. Warner also led Ontario’s legal team in creating the $250 million Ontario Emerging Technologies Fund with an emphasis on life-sciences companies, drafted funding agreements, including for the Ontario Research Fund and Ontario Brain Institute, and advised on legal and corporate governance issues in the formation of Clinical Trials Ontario.

In addition, Mr. Warner, led the Province’s legal team for the insolvency / restructuring of General Motors and Chrysler in the difficult context of the 2008-2009 Recession.

Original broadcast / publication source:Visit Wall Street Journal

Share this article

Share this insight with your network or send via email.

Topic Keywords:

American Antitrust LawyerAmerican Trade LawyerAstraZenecaCanadian Competition LawyerCanadian Trade LawyerComplianceCOVID-19Covid19FDAGovernment Procurement
Mark Warner

Mark Warner

Principal · MAAW LAW

Mark Warner is a business-oriented, results-driven, senior international business and regulatory expert with private practice, government, and academic experience in Canada, the United States, Europe and major emerging markets.